Of the 30 companies in the index, 20 saw their share prices decline, while four saw their stock prices rise and two were flat month over month.

The organization updated its guidelines to account for changes in the illegal drug supply as well as advances in technologies used for drug detection.

The HRSA screening guidelines now recommend use of either clinician-collected or patient-collected samples for human papillomavirus testing.

The rapid molecular chlamydia and gonorrhea self-test provides results in 30 minutes from a self-collected swab sample, the firm said.

NEW YORK – Kiffik Biomedical said earlier this month that it has closed an oversubscribed Series A financing round. According to the Miami, Florida-based company, it raised $20 million in the round.

NEW YORK – In a year when the broader economy put pressure on many diagnostics firms, stories about how some companies ultimately succumbed to macroeconomic forces grabbed readers' interest, as did ...

The SD Biosensor Standard Q COVID-19 Ag Test and Acon Biotech Flowflex SARS-CoV-2 Antigen Rapid Test were previously listed under WHO's emergency use listing.

NEW YORK – Increased commercial alliances, regulatory clearances, and academic evaluations helped advance digital pathology into the mainstream in 2025 and toward further adoption in the coming years.

NEW YORK – Italian in vitro diagnostics firm Diasorin said on Sunday that the US Food and Drug Administration has issued 510(k) clearance and CLIA-waived the firm's first assay for use on the Liaison ...

NEW YORK - The US Food and Drug Administration granted 510(k) marketing clearances in November to Roche Molecular Systems, Cytovale, Truvian Health, and others for infectious disease pathogen ...